Home
Live Updates
EQS-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Present a Clinical Update on its Novel Oral Small Molecule Varoglutamstat at Clinical Trials on Alzheimers Disease Conference (CTAD) : vimarsana.com
EQS-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Present a Clinical Update on its Novel Oral Small Molecule Varoglutamstat at Clinical Trials on Alzheimer's Disease Conference (CTAD)
EQS-News: Vivoryon Therapeutics N.V. / Key word(s): Conference Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Present a Clinical Update on its Novel Oral Small Molecule Varoglutamstat
Related Keywords
Germany ,
Munich ,
Bayern ,
Berlin ,
San Francisco ,
California ,
United States ,
Amsterdam ,
Noord Holland ,
Netherlands ,
Julie Seidel ,
Valeria Fisher ,
Halle Saale ,
Michael Schaeffer ,
Frank Weber ,
Hilton Union Square ,
News Service ,
Trophic Communications ,
Distribution Services ,
Vivoryon Therapeutics ,
Clinical Update ,
Novel Oral Small Molecule Varoglutamstat ,
Clinical Trials ,
Disease Conference ,
Euronext Amsterdam ,
Study Investigating Varoglutamstat ,
Dose Selection ,
Interim Blinded Safety ,
Imperial Ballroom ,
Corporate News ,
Regulatory Announcements ,
Unofficial Market ,
News ,
Vivoryon ,
Herapeutics ,
Resent ,
Linical ,
Pdate ,
Ovel ,
Ral ,
Mall ,
Olecule ,
Aroglutamstat ,
Rials ,
Lzheimer ,
Isease ,
Onference ,
Tad ,
vimarsana.com © 2020. All Rights Reserved.